Form 4 · LLY
Eli Lilly director Ralph Alvarez reports an award of about 10 shares
Ralph Alvarez, an Eli Lilly director, filed a Form 4 on Oct 20, 2026 at 4:32 PM ET reporting transactions on Oct 19, 2026.
The filing reports about 10 shares in a grant or award (code A).
After these transactions, the filing lists about 55,848 shares held directly.
Effect on holdings
Taken together, the rows reported here raised Ralph Alvarez's directly held shares by less than 0.1%, from about 55,838 to about 55,848.
Reporting person
- Ralph Alvarez, director (as filed: Alvarez Ralph)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | A | Common Stock | 10 | $1,240.34 | Acquired | 55,848 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Oct 20, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Eli Lilly company file → · More Eli Lilly filings
Disclosures
- Editor holdings in LLY
- The editor holds no position in Eli Lilly (LLY). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.